June Yue Yan Leung

June Yue Yan Leung

Auto-generated profile, based on publicly available information

June Yue Yan Leung

SHORE and Whāriki Research Centre, College of Health, Massey University, Auckland, New Zealand

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Preventive Medicine
Verified
Journal Article
Closed access
Jie Jane ZhaoJie Jane Zhao
Jie Jane Zhao
JLJune Yue Yan Leung
June Yue Yan Leung
SLShi Lin Lin
Shi Lin Lin
CSCatherine Mary Schooling
Catherine Mary Schooling

26 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Jie Jane ZhaoJie Jane Zhao
Jie Jane Zhao
WYWai Fung Yeung
Wai Fung Yeung
YCYap-Hang Chan
Yap-Hang Chan
Dana VackovaDana Vackova
Dana Vackova
JLJune Y. Y. Leung
June Y. Y. Leung
CSCatherine Mary Schooling
Catherine Mary Schooling
Cardiovascular disease (CVD) is a major contributor to the global burden of disease. Berberine, a long-standing, widely used, traditional Chinese medicine, is thought to have beneficial effects on CVD risk factors and in women with polycystic ovary syndrome. The mechanisms and effects, specifically in men, possibly via testosterone, have not been examined previously. To assess the effect of berberine on CVD risk factors and any potential pathway via testosterone in men, we conducted a randomized, double-blind, placebo-controlled, parallel trial in Hong Kong. In total, 84 eligible Chinese men with hyperlipidemia were randomized to berberine (500 mg orally, twice a day) or placebo for 12 weeks. CVD risk factors (lipids, thromboxane A2, blood pressure, body mass index and waist–hip ratio) and testosterone were assessed at baseline, and 8 and 12 weeks after intervention. We compared changes in CVD risk factors and testosterone after 12 weeks of intervention using analysis of variance, and after 8 and 12 weeks using generalized estimating equations (GEE). Of the 84 men randomized, 80 men completed the trial. Men randomized to berberine had larger reductions in total cholesterol (−0.39 mmol/L, 95% confidence interval (CI) −0.70 to −0.08) and high-density lipoprotein cholesterol (−0.07 mmol/L, 95% CI −0.13 to −0.01) after 12 weeks. Considering changes after 8 and 12 weeks together, berberine lowered total cholesterol and possibly low-density lipoprotein-cholesterol (LDL-c), and possibly increased testosterone. Changes in triglycerides, thromboxane A2, blood pressure, body mass index and waist–hip ratio after the intervention did not differ between the berberine and placebo groups. No serious adverse event was reported. Berberine is a promising treatment for lowering cholesterol. Berberine did not lower testosterone but instead may increase testosterone in men, suggesting sex-specific effects of berberine. Exploring other pathways and assessing sex differences would be worthwhile, with relevance to drug repositioning and healthcare.

1 February 2019 in Preventive Medicine
Verified
Journal Article
Closed access
JWJiao Wang
Jiao Wang
MKMan Ki Kwok
Man Ki Kwok
SYShiu Lun Au Yeung
Shiu Lun Au Yeung
ALAlbert Martin Li
Albert Martin Li
HLHugh Simon Lam
Hugh Simon Lam
CSCatherine Mary Schooling
Catherine Mary Schooling

16 May 2015 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
JLJune Y.Y. Leung
June Y.Y. Leung
ALAlbert M. Li
Albert M. Li
GLGabriel M. Leung
Gabriel M. Leung
CSCatherine Mary Schooling
Catherine Mary Schooling

5 December 2014 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
CSCm Schooling
Cm Schooling
WCWm Chan
Wm Chan
SLSl Leung
Sl Leung
TLTai-Hing Lam
Tai-Hing Lam
SLSy Lee
Sy Lee
GLGm Leung
Gm Leung
The Department of Health Elderly Health Service Cohort in Hong Kong was set up to promote understanding of ageing in a global context, to exploit the role of Hong Kong as a sentinel for populations currently experiencing very rapid economic development, to provide a developed non-Western ‘social laboratory’ where empirically derived hypotheses can be tested and to leverage the different patterns of common chronic diseases between East and West to generate novel hypotheses about their determinants. The initial cohort enrolled from July 1998 to the end of December 2001 includes 66 820 people aged 65 years or older, forming about 9% of the population of this age. A comprehensive health assessment was made at enrolment and then repeated regularly on an ongoing basis. The health assessment included a comprehensive assessment of lifestyle, social circumstances, physical health and mental health, including an assessment of cognition and depressive symptoms. Health services use and deaths have been obtained by record linkage and confirmed, where necessary, by telephone interview. Currently, the data are not publicly available; we would welcome collaborations and research proposals.

6 January 2016 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Closed access
PDF file
JLJune Y. Y. Leung
June Y. Y. Leung
HLHugh Simon Lam
Hugh Simon Lam
GLGabriel M. Leung
Gabriel M. Leung
CSCatherine Mary Schooling
Catherine Mary Schooling